<DOC>
	<DOCNO>NCT01003483</DOCNO>
	<brief_summary>The purpose study compare influence Orlistat Metformin obesity treatment obese PCOS woman .</brief_summary>
	<brief_title>Metformin Versus Orlistat Obese Polycystic Ovary Syndrome ( PCOS ) Patients</brief_title>
	<detailed_description>In randomized clinical trial study , 80 obese woman BMIâ‰¥30 , oligomenorrhae , hirsutism presence &gt; 12 ovarian follicle ( 2-10mm diameter ) , evaluate . In metformin group , metformin administer patient 1500 mg daily three month . In orlistate group , patient use orlistat tablet ( 120 mg , 3 time day ) three month . BMI , serum LH FSH level , serum triglyceride cholesterol level also patient ' ovulation compare treatment .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Orlistat</mesh_term>
	<criteria>BMI &gt; = 30 PCOS Drug use last three month</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>metformin</keyword>
	<keyword>orlistat</keyword>
	<keyword>pcos</keyword>
	<keyword>obese</keyword>
</DOC>